Phase 1 data presentations and peer-reviewed publications
Press
Release on Trial 03-103 results
Phase 2 data presentations and peer-reviewed
publications
Press Release on Trial 03-104 results
Press Release on Trial 03-105 results
Press Release on Trial 03-108 results
Press Release on Trial 03-109 results
(diquafosol tetrasodium ophthalmic solution) 2% for dry eye - Phase 3; Approvable
Denufosol tetrasodium inhalation solution for cystic fibrosis - Phase 3
(azithromycin ophthalmic solution) 1% for blepharitis - Phase 2
INS115644 and INS117548 for glaucoma - Phase 1